Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2005
11/23/2005EP1597369A1 Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions
11/23/2005EP1597360A2 Antiplasmin cleaving enzyme
11/23/2005EP1596871A2 T cell regulation
11/23/2005EP1596804A2 SOLUBLE FcyR FUSION PROTEINS AND METHODS OF USE THEREOF
11/23/2005EP1402006A4 Compositions and methods for high-level, large-scale production of recombinant proteins
11/23/2005EP1381628B1 Inflammation-specific peptides and the uses thereof
11/23/2005EP1226264B1 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus
11/23/2005EP1194161B1 Stable factor viii compositions
11/23/2005EP0939817B1 High-affinity interleukin-4 muteins
11/23/2005EP0837939B1 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/23/2005EP0835305B1 Cytokine that induces apoptosis
11/23/2005EP0781344B1 Novel implant and novel vector for the treatment of acquired diseases
11/23/2005EP0770129B1 Zinc finger protein derivatives and methods therefor
11/23/2005CN1701121A Improved transfection of eukaryontic cells with linear polynucleotides by electroporation
11/23/2005CN1701119A Methods for increasing the production of a recombinant polypeptide from a host cell
11/23/2005CN1701117A Antibody against enzyme specifically cleaving VON WILLEBRAND factor and assay system using the same
11/23/2005CN1699589A Process for preparing peptidoglycan
11/23/2005CN1228450C Antigenic preparations
11/22/2005US6967246 For stimulating release of tumor necrosis factor and or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
11/22/2005US6967245 Ucp5
11/22/2005US6967108 use of human monoclonal antibodies in a method for detecting antibodies to IA-2, a method for detecting antibodies to the islet cell antigen IA-2 and a method for detecting the islet cell antigen IA-2 in a sample
11/22/2005US6967106 Purification; removal by-products; side effect reduction
11/22/2005US6967090 Nucleic acid and protein sequences of bovine epidermal growth factor
11/22/2005US6967089 Delivery system for porcine somatotropin
11/22/2005US6967076 A reporter sequence consists of a reporter gene whose expression is regulated by a protein specific to HIV viruses, expressed from a genome of an HIV virus upon infection of a cell tranduced by genetic engineered viral vector
11/22/2005CA2174081C Membrane protein polypeptide having function of supporting pre-b cell growth and gene therefor
11/17/2005WO2005108985A1 Method of judging systemic arteriosclerosis and judgement reagent
11/17/2005WO2005108617A2 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/17/2005WO2005108596A1 Method for producing cyclic peptides from in vitro plant cell cultures
11/17/2005WO2005108567A1 Method of constructing modified protein
11/17/2005WO2005108553A1 Method for culturing the nitrile hydratase-producing strain rodococcus rhodochrous m33
11/17/2005WO2005108429A1 Novel soluble cd14 antigen
11/17/2005WO2005108428A2 Cd40 splice variants and their uses
11/17/2005WO2005108427A2 Method for producing soluble mhc proteins
11/17/2005WO2005047309A3 Prophylactic and therapeutic monoclonal antibodies
11/17/2005WO2004078140A3 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
11/17/2005WO2003042399A8 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/17/2005WO2001072768A8 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
11/17/2005WO1997049725A9 Modified factor viii
11/17/2005US20050256304 Modified factor VIII
11/17/2005US20050256303 Having antibacterial activity, antioxidative effect, inflammation inhibitory effect, in vivo substance transporting action, and enzymatic activity, used as a drug administration carrier
11/17/2005US20050256299 Vaccines
11/17/2005US20050256075 Use of VEGF-C or VEGF-D gene or protein to prevent restenosis
11/17/2005US20050256057 Proline-specific endoprotease and tripeptidase digested polypeptide mixture comprising tripeptides for use in pharmaceuticals and nutraceuticals
11/17/2005US20050256052 Isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation; binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes
11/17/2005US20050256050 Vascular endothelial growth factor 2
11/17/2005US20050256049 Chimeric toxins for targeted therapy
11/17/2005US20050256042 Methods of preventing and treating alimentary mucositis
11/17/2005US20050256039 Novel fibroblast growth factors and methods of use thereof
11/17/2005US20050255591 Transplanting human hepatocytes into a liver of an immunodeficient hepatopathy mouse, feeding the mouse transplanted under such a condition as being protected from the attack by human complement produced by the human hepatocytes thereby proliferating the transplanted human hepatocytes in the mouse liver
11/17/2005US20050255560 Ztnf11, a tumor necrosis factor
11/17/2005US20050255558 Signal sequence polypeptides for diagnosis, prevention and treatment of metabolic disorders
11/17/2005US20050255557 Novel compounds
11/17/2005US20050255555 Monoclonal antibody specific to epidermal growth factor receptor for targeting tumors and treating cancer; tissue targeted therapy
11/17/2005US20050255554 Fusion peptides isolatable by phase transition
11/17/2005US20050255553 Mage C2 antigenic peptides and uses thereof
11/17/2005US20050255552 Antibody specificity transfer using minimal essential binding determinants
11/17/2005US20050255551 Methods and compositions relating to chimeric nicotinic receptor subunits
11/17/2005US20050255548 Protein scaffolds for antibody mimics and other binding proteins
11/17/2005US20050255547 Hexamers of receptors, members of the tnf receptor family, their use in therapy and pharmaceutical compositions comprising the same
11/17/2005US20050255545 Regulation of human hematopoietin receptor-like protein
11/17/2005US20050255542 Expressing a thioredoxin-fused membrane protein, particularly a G protein-coupled receptor, in a cell-free system that preferably contains a nonionic detergent
11/17/2005US20050255531 Signal transduction
11/17/2005US20050255520 Cardiac-related Ankyrin-Repeat Protein Kinase (CARK); specifically binds to polypeptide encoded by nucleic acid; labeled or conjugated to therapeutic agent; treatment of cardiovascular disorders
11/17/2005US20050255513 Regulatable growth of filamentous fungi
11/17/2005US20050255496 Ztnf12, a tumor necrosis factor
11/17/2005US20050255449 Targeted fusion proteins and methods for the characterization of cellular membrane domains
11/17/2005US20050255115 T-cell surface glycoprotein specific immunoglobulin for use in treatment and prevention of cell proliferative disorders; immunotherapy
11/17/2005US20050255101 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
11/17/2005US20050255099 Antigenic fusion protein carrying Galalpha 1,3Gal epitopes
11/17/2005US20050255094 Mitogen-activated protein kinase kinase MEK6 and methods of use therefor
11/17/2005DE10392697T5 Herstellung und Standardisierung von immunmodulierenden Peptid-verknüpften Glucanen mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor Preparation and standardization of immunomodulating peptide-linked glucans with detectable oral absorbability from Coriolus Versicolor
11/17/2005CA2566101A1 Novel soluble cd14 antigen
11/17/2005CA2563521A1 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/16/2005EP1595951A1 Diagnosis and treatment of diseases using peptides which are bound by specific anti-anti-t-cell receptor vbeta antibodies
11/16/2005EP1595947A1 MN gene and protein
11/16/2005EP1594889A2 Nell peptide expression systems and bone formation activity of nell peptide
11/16/2005EP1594888A2 Tolerance-induced targeted antibody production
11/16/2005EP1594543A2 Immunogene adherence and method of making and using the same
11/16/2005EP1594533A2 Antibody vaccine conjugates and uses therefor
11/16/2005EP1594530A2 Albumin fusion proteins
11/16/2005EP1594435A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/16/2005EP1490768A4 Adaptive behavioral intrusion detection systems and methods
11/16/2005EP1082423B1 Cyclin e2 genes and proteins
11/16/2005EP1068328B1 Treatment and diagnosis of staphylococcal infections
11/16/2005EP0871703B1 Dna encoding glutamate gated chloride channels
11/16/2005EP0832232B1 Kunitz type plasma kallikrein inhibitors
11/16/2005EP0818532B1 Plant promoter and gene expression with the use of the same
11/16/2005EP0749491B1 Enhanced expression in a plant plastid
11/16/2005EP0651811B1 K. lactis rp28 ribosomal protein gene promoter and use thereof
11/16/2005EP0556207B2 Modified human tnfalpha (tumor necrosis factor alpha) receptor
11/16/2005EP0477295B2 Platelet aggregation inhibitors
11/16/2005CN1696304A Method for preparing recombined apoptosis induction ligand relevant to human soluble tumor necrosis factor
11/16/2005CN1227533C Reagent for diagnosing cardiac infarction
11/16/2005CN1227365C Process for producing protein hydrolyzate
11/16/2005CN1227363C Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same
11/16/2005CN1227352C Method for producing protein feed by fermenting the waste water from saponin production
11/16/2005CN1227265C Antibodies to CCR5
11/16/2005CN1227264C Immunogenic peptides derived from MAGE and use thereof
11/15/2005US6965060 Production of silk-like proteins in plants
1 ... 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 ... 1125